We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WDFC:NASDAQWD-40 Company Analysis

Data as of 2026-05-28 - not real-time

$205.53

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

WD-40 Company trades near the 20‑day SMA, which sits just below the 50‑day SMA, suggesting a market that is neither strongly bullish nor bearish. The RSI hovers in the mid‑40s, indicating that the stock is not yet oversold and retains modest upside potential. A bullish MACD histogram, with the line above the signal, adds a subtle technical positive bias despite the overall neutral trend. Current price sits above the identified support at $198 but below the resistance near $217, giving the stock a clear trading range. Volume has been decreasing, hinting at a potential slowdown in short‑term buying pressure. The beta of roughly 0.1 signals minimal correlation with broader market moves, while 30‑day volatility above 25% reflects notable price swings. Fundamentally, revenue is growing at double‑digit rates and margins remain robust, yet the trailing PE near 35 and a price‑to‑book above 10 signal a premium valuation. The DCF‑derived fair value of under $95 is dramatically lower than the market price, implying the stock is currently overvalued. Dividend yield of just under 2% with a payout ratio around 65% appears sustainable given strong free cash flow. The Fear & Greed Index sits in “Extreme Greed,” suggesting investor sentiment may be overly optimistic. A max drawdown of roughly 24% underscores the downside risk if market sentiment shifts. Overall, the blend of solid fundamentals and a stretched valuation creates a nuanced outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price positioned between support and resistance
  • Bullish MACD histogram
  • Decreasing volume indicating caution

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and operating margins
  • Sustainable dividend with solid cash flow
  • Significant valuation premium versus DCF fair value

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Market price far above DCF fair value
  • High PE and P/B ratios
  • Extreme Greed sentiment and potential correction risk

Key Metrics & Analysis

Financial Health

Revenue Growth10.70%
Profit Margin12.57%
P/E Ratio35.0
ROE31.30%
ROA14.07%
Debt/Equity41.30
P/B Ratio10.3
Op. Cash Flow$89.3M
Free Cash Flow$64.8M

Technical Analysis

TrendNeutral
RSI45.6
Support$198.35
Resistance$217.20
MA 20$206.54
MA 50$210.64
MA 200$210.62
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

Fair Value$94.87
Target Price$249.50
Upside/Downside21.39%
GradeOvervalued
TypeBlend
Dividend Yield1.91%

Risk Assessment

Beta0.10
Volatility27.13%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.